• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】52015

【品名】3-(4-bromophenoxy)-5-chloroisonicotinaldehyde

【CA登记号】

【 分 子 式 】C12H7BrClNO2

【 分 子 量 】312.54982

【元素组成】C 46.11% H 2.26% Br 25.57% Cl 11.34% N 4.48% O 10.24%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(V)

The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is hydrolyzed with LiOH in THF/water to provide the corresponding carboxylic acid (VIII). Finally, this compound is condensed with methylamine (IX) by means of EDC and HOBt in DMF to give the target amide. Alternatively, the target amide can also be obtained by direct reaction of methyl ester (VII) with methylamine (IX) in hot methanol in a sealed tube.

1 Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
2 Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35535 3,5-dichloropyridine 2457-47-8 C5H3Cl2N 详情 详情
(II) 45474 methyl formate 107-31-3 C2H4O2 详情 详情
(III) 35536 3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde 136590-83-5 C6H3Cl2NO 详情 详情
(IV) 25313 4-bromophenol 106-41-2 C6H5BrO 详情 详情
(V) 52015 3-(4-bromophenoxy)-5-chloroisonicotinaldehyde C12H7BrClNO2 详情 详情
(VI) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(VII) 52016 methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate C15H10BrNO3S 详情 详情
(VIII) 52017 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid C14H8BrNO3S 详情 详情
(IX) 11021 Methanamine; Methylamine 74-89-5 CH5N 详情 详情

合成路线2

该中间体在本合成路线中的序号:(V)

The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is finally treated with hot methanolic ammonia in a sealed tube to give the target amide.

1 Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
2 Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35535 3,5-dichloropyridine 2457-47-8 C5H3Cl2N 详情 详情
(II) 45474 methyl formate 107-31-3 C2H4O2 详情 详情
(III) 35536 3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde 136590-83-5 C6H3Cl2NO 详情 详情
(IV) 25313 4-bromophenol 106-41-2 C6H5BrO 详情 详情
(V) 52015 3-(4-bromophenoxy)-5-chloroisonicotinaldehyde C12H7BrClNO2 详情 详情
(VI) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(VII) 52016 methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate C15H10BrNO3S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(V)

The formylation of 3,5-dichloropyridine (I) with methyl formate (II), BuLi and DIEA in THF gives 3,5-dichloropyridine-4-carbaldehyde (III), which is treated with 4-bromophenol (IV) and potassium tert-butoxide in hot THF to yield the adduct (V). This compound, without isolation is cyclized with methyl 2-mercaptoacetate (VI) by means of Cs2CO3 to afford 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid methyl ester (VII), which is hydrolyzed with LiOH in THF/water to provide the corresponding carboxylic acid (VIII). Finally, this compound is condensed with ethanolamine (IX) by means of EDC and HOBt in DMF to give the target ethanolamide. Alternatively, the target amide can also be obtained by direct reaction of methyl ester (VII) with ethanolamine (IX) in refluxing methanol.

1 Zhu, G.-D.; et al.; Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)theino[2,3-c]pyridines with fine-tuning at C-2 carbamides. J Med Chem 2001, 44, 21, 3469.
2 Lartey, K.; Gunawardana, I.W.; Stout, D.M.; Bhatia, P.; Patel, M.V.; Staeger, M.A.; Boyd, S.A.; Mort, N.A.; Zhu, G.-D.; McCarty, C.M.; Stewart, A.O.; Arendsen, D.L.; Condroski, K.R.; Freeman, J.C. (Abbott Laboratories Inc.); Cell adhesion-inhibiting antiinflammatory cpds.. WO 9962908 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 35535 3,5-dichloropyridine 2457-47-8 C5H3Cl2N 详情 详情
(II) 45474 methyl formate 107-31-3 C2H4O2 详情 详情
(III) 35536 3,5-dichloroisonicotinaldehyde; 3,5-Dichloropyridine-4-carbaldehyde 136590-83-5 C6H3Cl2NO 详情 详情
(IV) 25313 4-bromophenol 106-41-2 C6H5BrO 详情 详情
(V) 52015 3-(4-bromophenoxy)-5-chloroisonicotinaldehyde C12H7BrClNO2 详情 详情
(VI) 18838 methyl 2-sulfanylacetate 2365-48-2 C3H6O2S 详情 详情
(VII) 52016 methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate C15H10BrNO3S 详情 详情
(VIII) 52017 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylic acid C14H8BrNO3S 详情 详情
(IX) 13324 2-Methylaminoethanol; 2-(Methylamino)-1-ethanol 109-83-1 C3H9NO 详情 详情
Extended Information